Pediapharm Inc. | Income Statement
Fiscal year is April-March. All values CAD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
3,745.40
3,068.70
3,750.20
6,207.10
10,009.20
Cost of Goods Sold (COGS) incl. D&A
-
-
1,401.70
2,802.40
4,981.80
Gross Income
-
-
2,348.50
3,404.80
5,027.30
SG&A Expense
6,577.90
7,984.80
6,533.60
6,803.70
7,862.40
EBIT
2,921.90
5,033.20
4,185.10
3,398.90
2,835.10
Unusual Expense
-
-
217.00
-
475.70
Non Operating Income/Expense
17.50
15.00
3,062.40
2,609.40
23.60
Interest Expense
347.90
-
1,001.00
1,082.30
1,186.70
Pretax Income
3,263.70
4,998.90
2,299.30
1,831.90
3,482.60
Consolidated Net Income
3,263.70
4,998.90
2,299.30
1,831.90
3,482.60
Net Income
3,263.70
4,998.90
2,299.30
1,831.90
3,482.60
Net Income After Extraordinaries
3,263.70
4,998.90
2,299.30
1,831.90
3,482.60
Net Income Available to Common
3,263.70
4,998.90
2,299.30
1,831.90
3,482.60
EPS (Basic)
0.14
0.07
0.03
0.02
0.04
Basic Shares Outstanding
23,709.70
72,055.90
72,381.60
72,634.20
85,239.30
EPS (Diluted)
0.14
0.07
0.03
0.03
0.04
Diluted Shares Outstanding
23,709.70
72,055.90
72,381.60
72,634.20
85,239.30
EBITDA
2,832.50
4,916.10
4,037.80
3,347.00
2,603.90
Non-Operating Interest Income
23.50
49.20
41.50
40.00
39.80
About Pediapharm
View Profile
